# Progress Note 04 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Michelangelo Buonarroti (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-RE002-SYN
- Date: 2026-07-13
- Fictional facility: St. Posthumous Health Center
- Fictional author: Serena Castellano, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Hand osteoarthritis review three months after the thumb-base injection. **S**

## History of present illness

Mr. Buonarroti returns three months after the left thumb-base injection. The planned review four to six weeks after the injection did not take place; a nurse called him at five weeks and recorded that his hand was much better, but no pain or function score was taken. He completed four sessions of hand therapy between mid-May and mid-June and does his thumb exercises each morning. He now carves with padded chisel grips, a lighter mallet, and the splint, and rests his hand every 45 minutes. The finger cut from early June healed, and the sutures came out at 11 days. His pain is about 3 of 10, and he can write a short letter with a thick-barrelled pen. He takes acetaminophen 1 g most mornings and uses the gel twice a day. No gout flare, stones, falls, or ibuprofen. **S**

| Element | Detail |
|---|---|
| Pain | About 3 of 10; worse after long sessions |
| Function | Carving about three hours a morning; writes short letters with a thick pen |
| Hand therapy | Four sessions completed; daily home exercises |
| Missed review | No scored review at four to six weeks after the injection; nurse telephone call at five weeks only |
| Finger wound | Healed; sutures out at 11 days |
| Analgesics | Acetaminophen 1 g most mornings; gel twice a day; no oral NSAIDs |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Musculoskeletal | Positive | Mild left thumb-base ache after long work; no joint swelling or foot pain |
| Integumentary | Negative | Finger wound healed; no rash |
| Neurological | Negative | No numbness in the hand; no dizziness or falls |

3 systems reviewed. **S**

## Current medications

- Allopurinol 100 mg oral tablet, two tablets (200 mg) by mouth daily **S**
- Diclofenac sodium 1% topical gel, 2 g to the painful hand joints four times daily, no more than 8 g a day to either hand **S**
- Acetaminophen 500 mg oral tablet, two tablets by mouth up to three times daily as needed for hand pain, no more than 3 g a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 132/76 mmHg; pulse 68 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 61.4 kg; BMI 21.8 kg/m². All vital signs are synthetic.

Hand pain (0-10 numeric rating): 3; PROMIS upper extremity T-score: 42; Grip strength, left hand: 17 kg; Grip strength, right hand: 23 kg. All results are synthetic.

## Change since baseline

- Hand pain (0-10 numeric rating): 7 at baseline, 3 at this visit **S**
- PROMIS upper extremity T-score: 33 at baseline, 42 at this visit **S**
- Grip strength, left hand: 14 kg at baseline, 17 kg at this visit **S**
- Grip strength, right hand: 22 kg at baseline, 23 kg at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well |
| Left hand | Thumb-base squaring with mild tenderness; grind test mildly positive; no synovitis; healed scar over the index finger with full extension |
| Right hand | Heberden nodes; no synovitis |
| Gait | Steady, unaided |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Left hand osteoarthritis** (M19.042). Clear improvement: pain 3 of 10 (from 7 at intake), PROMIS upper extremity T-score 42 (from 33), left grip 17 kg (from 14). The injection, hand therapy, splinting, and tool changes are working together. **S**
   - Continue exercises, splint, gel, and acetaminophen as needed.
   - A repeat injection only if pain returns, no sooner than three months after the last.
   - Thumb-base surgery is not needed at this level of pain and function.
2. **Gout** (M1A.9XX0). No flare. **S**
   - Serum urate in October, six months after the last.
3. **History of urinary stones** (Z87.442). No symptoms. **S**
   - Continue about 2 L of water a day.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Hand pain, 0 to 10 numeric rating | Each clinical encounter; after each therapeutic trial | Completed today | 3 of 10, down from 5 in April and 7 at intake |
| Survey | Validated function measure (PROMIS upper extremity T-score; AUSCAN and FIHOA have no LOINC code) | Each clinical encounter | Completed today | T-score 42 (population mean 50; higher is better) |
| Examination | Grip strength by dynamometer | Each clinical encounter in this plan | Completed today | Left 17 kg, right 23 kg |
| Survey | Pain and function reassessment 4 to 6 weeks after the injection | After each therapeutic trial | Deferred | Not done: no review was booked, a deviation from the protocol; a nurse telephone call at five weeks recorded improvement without a score. No harm: the scores today show a good response. Corrective action: post-injection reviews are now booked at the time of the injection |
| Examination | Joint examination | Each clinical encounter | Completed today | No synovitis; tenderness reduced |
| Referral | Occupational hand therapy | First-line care | Completed today | Four sessions completed from mid-May to mid-June; home program continues |
| Medication safety | Analgesic review: no oral NSAIDs; acetaminophen dose | Each clinical encounter | Completed today | No ibuprofen; acetaminophen about 1 g a day; gel twice a day |
| Laboratory | ALT on regular acetaminophen | Periodically | Due | Due at the October review |
| Self-management | Exercise, joint protection, splint, and tool adaptation | Each clinical encounter | Completed today | Daily exercises; padded grips, a lighter mallet, and rest breaks every 45 minutes |
| Self-management | Gait, balance, and activities of daily living | Ongoing | Completed today | Independent; no falls; never climbs a ladder alone |
| Survey | Mood, sleep, and coping screen | Periodically | Due | No concerns raised; PHQ-2 planned at the wellness visit |
| Laboratory | Serum urate | Every 6 months at target | Up to date | 5.4 mg/dL in March; due in October |

## Goal progress

- Hand pain at or below 3 of 10 on most days by the seven-month review. In progress; target 2026-10-19. **S**
- Carve for at least three hours a morning and write his own letters. In progress; target 2026-10-19. **S**
- No oral NSAID use and creatinine back to his baseline. Outcome by 2026-04-13: Ibuprofen stopped; creatinine from 1.21 to 1.02 mg/dL. **S**
- Serum urate below 6 mg/dL and no gout flare or stone. In progress; target 2026-10-19. **S**
- No falls, with safe ladder and scaffold use. In progress; target 2026-10-19. **S**

## Guideline basis

- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019), American College of Rheumatology and Arthritis Foundation (Arthritis Rheumatol 2020;72(2):220-233)
- 2020 American College of Rheumatology Guideline for the Management of Gout (2020), American College of Rheumatology (Arthritis Care Res 2020;72(6):744-760)
- Medical Management of Kidney Stones: AUA Guideline (2014, amended 2019), American Urological Association
- American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023), American Geriatrics Society (J Am Geriatr Soc 2023;71(7):2052-2081)
- CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis monograph (2026), Aether Forge

## Follow-up

- Annual wellness visit in September. Hand and gout review in October with serum urate, kidney tests, and ALT. **S**
- Next scheduled visit 2026-09-14: subsequent annual wellness visit. **S**
